DK1265604T3 - Proces til udvinding af statinforbindelser fra en gæringsvæske - Google Patents

Proces til udvinding af statinforbindelser fra en gæringsvæske

Info

Publication number
DK1265604T3
DK1265604T3 DK00980834T DK00980834T DK1265604T3 DK 1265604 T3 DK1265604 T3 DK 1265604T3 DK 00980834 T DK00980834 T DK 00980834T DK 00980834 T DK00980834 T DK 00980834T DK 1265604 T3 DK1265604 T3 DK 1265604T3
Authority
DK
Denmark
Prior art keywords
extracting
statin compounds
fermentation fluid
fermentation
fluid
Prior art date
Application number
DK00980834T
Other languages
Danish (da)
English (en)
Inventor
Vilmos Keri
Lajos Deak
Ilona Forgacs
Csaba Szabo
Edit Arvai Nagyne
Original Assignee
Teva Gyogyszergyar Zartkoeruee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22609918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1265604(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Gyogyszergyar Zartkoeruee filed Critical Teva Gyogyszergyar Zartkoeruee
Application granted granted Critical
Publication of DK1265604T3 publication Critical patent/DK1265604T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Cardiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00980834T 1999-11-30 2000-11-28 Proces til udvinding af statinforbindelser fra en gæringsvæske DK1265604T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16805699P 1999-11-30 1999-11-30
PCT/US2000/032391 WO2001039768A1 (en) 1999-11-30 2000-11-28 Process for recovering statin compounds from a fermentation broth

Publications (1)

Publication Number Publication Date
DK1265604T3 true DK1265604T3 (da) 2007-02-05

Family

ID=22609918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00980834T DK1265604T3 (da) 1999-11-30 2000-11-28 Proces til udvinding af statinforbindelser fra en gæringsvæske

Country Status (22)

Country Link
US (3) US6444452B1 (sk)
EP (1) EP1265604B1 (sk)
JP (5) JP3881240B2 (sk)
KR (1) KR20030026920A (sk)
CN (2) CN1754872A (sk)
AT (2) ATE342717T1 (sk)
AU (1) AU1804601A (sk)
CA (1) CA2393057C (sk)
CY (1) CY1105925T1 (sk)
DE (3) DE60037687D1 (sk)
DK (1) DK1265604T3 (sk)
ES (2) ES2273737T3 (sk)
HR (1) HRP20020454A2 (sk)
HU (1) HUP0204012A3 (sk)
MX (1) MXPA02005283A (sk)
PL (1) PL364918A1 (sk)
PT (1) PT1265604E (sk)
RU (1) RU2002114072A (sk)
SK (1) SK7342002A3 (sk)
WO (1) WO2001039768A1 (sk)
YU (1) YU39102A (sk)
ZA (1) ZA200203912B (sk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
PT1265604E (pt) * 1999-11-30 2006-12-29 Teva Gyogyszergyar Zartkoeruen Processo para a recuperação de compostos de estatina de um caldo de fermentação
IL150187A0 (en) * 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
CZ20031166A3 (cs) * 2000-10-05 2004-04-14 Biogal Gyogyszergyar Rt Sodná sůl pravastatinu, která v podstatě neobsahuje pravastatin lakton a epi-pravastatin a kompozice na její bázi
US20050215636A1 (en) * 2000-10-05 2005-09-29 Vilmos Keri Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
JP2002121172A (ja) * 2000-10-16 2002-04-23 Sankyo Co Ltd プラバスタチン又はその薬理上許容される塩の精製方法
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
JP2003026634A (ja) * 2001-07-17 2003-01-29 Mercian Corp プラバスタチンナトリウム塩の製造方法
US6716615B2 (en) 2002-02-27 2004-04-06 Yung Shin Pharmaceutical Ind. Co., Ltd. Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase
KR100540761B1 (ko) * 2002-08-09 2006-01-16 코바이오텍 (주) 프라바스타틴 나트륨의 제조방법
EP1477471A1 (en) * 2003-05-14 2004-11-17 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Process for purifying pravastin sodium from a fermentation broth
ATE412409T1 (de) * 2003-11-24 2008-11-15 Teva Gyogyszergyar Zartkoeruee Verfahren zur reinigung von pravastatin
US7473366B2 (en) * 2003-12-05 2009-01-06 Biocon Limited Process for the purification of macrolides
WO2006046130A2 (en) * 2004-10-29 2006-05-04 Ranbaxy Laboratories Limited Process for the preparation of pravastatin
TW200640854A (en) * 2005-02-09 2006-12-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods of making pravastatin sodium
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
DE102006028817A1 (de) * 2006-06-21 2007-12-27 Evonik Degussa Gmbh Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen
WO2009078033A2 (en) * 2007-12-18 2009-06-25 Themis Medicare Limited Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
EP2274267B1 (en) * 2008-04-02 2012-01-04 DSM IP Assets B.V. Pravastatin extraction
IN2009MU00380A (sk) * 2009-02-18 2010-04-02
CN102993145B (zh) * 2011-09-19 2015-06-03 北大方正集团有限公司 一种提取纯化洛伐他汀的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) * 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
EP0215665B1 (en) * 1985-09-13 1991-11-21 Sankyo Company Limited Hydroxy-ml-236b derivatives, their preparation and use
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857522A (en) * 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en) 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
EP0975789A1 (en) * 1997-02-20 2000-02-02 Dsm N.V. Nitrogen feed in statin fermentation
WO1999010499A1 (en) * 1997-08-22 1999-03-04 Dsm N.V. Statin production by fermentation
SI9800046A (sl) * 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
PL350317A1 (en) * 1999-02-03 2002-12-02 Inst Drug Res Ltd Microbial process for preparing pravastatin
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
PT1265604E (pt) * 1999-11-30 2006-12-29 Teva Gyogyszergyar Zartkoeruen Processo para a recuperação de compostos de estatina de um caldo de fermentação
CZ20031166A3 (cs) * 2000-10-05 2004-04-14 Biogal Gyogyszergyar Rt Sodná sůl pravastatinu, která v podstatě neobsahuje pravastatin lakton a epi-pravastatin a kompozice na její bázi

Also Published As

Publication number Publication date
EP1265604A4 (en) 2004-06-16
ATE342717T1 (de) 2006-11-15
SK7342002A3 (en) 2004-03-02
HUP0204012A2 (hu) 2003-03-28
HUP0204012A3 (en) 2003-12-29
CN1433305A (zh) 2003-07-30
EP1265604A1 (en) 2002-12-18
CY1105925T1 (el) 2011-04-06
EP1265604B1 (en) 2006-10-18
JP4343987B2 (ja) 2009-10-14
CA2393057C (en) 2008-01-29
YU39102A (sh) 2006-01-16
ES2273737T3 (es) 2007-05-16
JP2003515334A (ja) 2003-05-07
US20040115781A1 (en) 2004-06-17
US6444452B1 (en) 2002-09-03
DE60031447T2 (de) 2007-08-30
CA2393057A1 (en) 2001-06-07
AU1804601A (en) 2001-06-12
DE60031447D1 (de) 2006-11-30
US6689590B2 (en) 2004-02-10
JP2006273861A (ja) 2006-10-12
DE60037687D1 (de) 2008-02-14
JP2006055174A (ja) 2006-03-02
RU2002114072A (ru) 2004-07-20
ATE382344T1 (de) 2008-01-15
WO2001039768A1 (en) 2001-06-07
JP3881240B2 (ja) 2007-02-14
JP2008109948A (ja) 2008-05-15
HRP20020454A2 (en) 2005-10-31
KR20030026920A (ko) 2003-04-03
PL364918A1 (en) 2004-12-27
JP2004350687A (ja) 2004-12-16
MXPA02005283A (es) 2003-10-06
PT1265604E (pt) 2006-12-29
US20020187531A1 (en) 2002-12-12
ZA200203912B (en) 2003-08-21
CN1754872A (zh) 2006-04-05
DE04010770T1 (de) 2005-10-20
ES2239937T1 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
DK1265604T3 (da) Proces til udvinding af statinforbindelser fra en gæringsvæske
NO20020214L (no) Substituerte oksoazaheterocyklylforbindelser
MXPA03011681A (es) Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular.
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
PE20020707A1 (es) Compuestos tripeptidicos como inhibidores de la proteasa ns3 del virus de hepatitis c
DE69516866T2 (de) Stereochemische wortmanninderivate
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
EA199900301A2 (ru) Замещенные трициклические соединения
YU63602A (sh) Postupak za prečišćavanje fermentacionog bujona
MA23313A1 (fr) Systeme utilisant des photobioreacteurs tubulaires pour la culture industrielle des microrganismes photosynthetiques.
NO985511L (no) FremgangsmÕte for fremstilling av aminoalkoholderivater og deres videre omsetning til (1R,4S)-4-((2-amino-6-klor-5-formamido-4-pyrimidinyl)-amino)-2-cyklopenten-1-metanol
DK0577040T3 (da) Fremgangsmåde til fremstilling af (3R,5S)6-hydroxy-3,,5-O-isopropyliden-3,5-dihydroxyhexansyre-tert.-butylester
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
CO4700282A1 (es) Compuestos
EE04345B1 (et) Simvastatiini ja selle derivaatide valmistamise protsess
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
NO983511L (no) Difenylstilbener som pro-legemidler til COX-2-inhibitorer
DK1165491T3 (da) LTA4-hydrolase-inhibitorer
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
ATE485277T1 (de) Verfahren zur herstellung eines 3,5-dihydroxy-6- heptenoats
GB9923379D0 (en) A method of translating a source operation to a target operation
PT1673361E (pt) Método para o fabrico de lovastatina
NO20014989D0 (no) Fremstilling av pseudomycin fra Pseudomonas Syringae
FR2811742B1 (fr) Systeme destine a la production de cendres de combustion de dechets contenant de la cellulose
SE8203245L (sv) Forfarande for enantioselektiv framstellning av n-substituerade prolinderivat